We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Locates Gene Defects Linked to Cancer

By LabMedica International staff writers
Posted on 21 Jan 2014
A simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue.

This blood test appears possible following the discovery that tiny particles called exosomes, which are shed by cancer cells into the blood, contain the entire genetic blueprint of cancer cells and by decoding this genomic data and looking for deletions and mutations associated with cancer; these findings could be translated into a test that helps physicians detect cancer. More...


Scientists at The University of Texas MD Anderson Cancer Center (Houston, TX, USA) collected serum samples on the day of surgery from patients undergoing surgical resection of their tumors. The team investigated whether exosomes from pancreatic cancer cells and serum from patients with pancreatic ductal adenocarcinoma contain genomic DNA.

Exosomes were isolated from the serum samples and cell cultures. DNA was extracted and other techniques such as flow cytometry analysis, western blots were performed. The amount of DNA from cells and cell-derived exosomes was quantified using a Nanodrop 1000 Spectrophotometer (Thermo Fisher Scientific; Wilmington, DE, USA). Whole genome sequencing was performed using the ThruPLEX-FD library prep technology (Rubicon Genomics; Ann Arbor, MI, USA) in combination with the HiSeq2000 sequencing platform (Illumina; San Diego, CA, USA).

The scientists found evidence that exosomes contain greater than 10 kilobase (kb) fragments of double-stranded genomic DNA. Mutations in the V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and the tumor protein p53 can be detected using genomic DNA from exosomes derived from pancreatic cancer cell lines and serum from patients with pancreatic cancer. In addition, using whole genome sequencing, they demonstrate that serum exosomes from patients with pancreatic cancer contain genomic DNA spanning all chromosomes. These results indicate that serum derived exosomes can be used to determine genomic DNA mutations for cancer prediction, treatment, and therapy resistance.

Raghu Kalluri, MD, PhD, the senior author of the study, said, “At the present time, there is no single blood test that can screen for all cancer related DNA defects. In many cases, current protocols require a tumor sample to determine whether gene mutations and deletions exist and therefore determine whether the tumor itself is cancerous or benign. To procure tumor tissue, one needs to know that a tumor exists, and if so, is it accessible for sample collection or removal? Finally, there are always risks and significant costs associated with surgical procedures to acquire tumor tissue.” The study was published on January 7, 2014, in the Journal of Biological Chemistry.

Related Links:

The University of Texas MD Anderson Cancer Center
Thermo Fisher Scientific 
Rubicon Genomics



Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: Automated cell imaging discriminates CD8+ T cells according to natalizumab treatment outcome in MS patients (B Chaves et al., Nat Commun 16, 5533 (2025). DOI: 10.1038/s41467-025-60224-3)

Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients

Multiple sclerosis (MS) is a chronic autoimmune and degenerative neurological disease that affects the central nervous system, leading to motor, cognitive, and mental impairments. Symptoms can include... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: ELITechGroup’s unique Real-Time PCR technologies include the revolutionary Minor Groove Binder (Photo courtesy of ELITechGroup)

ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases

Molecular testing has become central to diagnosing and monitoring infectious diseases by analyzing genetic information. The use of PCR during the COVID-19 pandemic showed its value, but traditional systems... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.